What are your thoughts on trending beta-hydroxybutyrate once a diagnosis of DKA is already established?
Do you find it helpful to monitor for treatment response, resolution, and/or recurrence?
Answer from: at Community Practice
Beta-hydroxybutyrate (BOHB) ≥3.0 mmol/L is highly sensitive and specific for diagnosing DKA and can be measured through serum or point-of-care testing. However, its role in monitoring treatment response and determining resolution remains debated. The American Diabetes Association recommends conti...